AstraZeneca Executive and Leadership Team

Iris Zhang, the Chief Financial Officer at AstraZeneca, directs the overarching fiscal strategy and capital allocation processes. Overseeing global financial reporting, the Chief Financial Officer ensures rigorous compliance with international regulatory standards while optimizing resource distribution across diverse therapeutic areas. This leadership role involves constant collaboration with the Board to maintain long-term shareholder value through disciplined investment in research and development. By analyzing complex market data, Iris Zhang identifies emerging opportunities for growth within the biopharmaceutical sector. The Chief Financial Officer maintains a focus on operational efficiency, driving cost-effective practices that support the discovery and commercialization of life-saving medicines. Through precise financial modeling and risk assessment, Zhang secures the economic foundation necessary for the company to pursue ambitious scientific breakthroughs in oncology and immunology, ultimately strengthening the competitive position of the organization in the global marketplace.

Santiago Rivera, the Chief Financial Officer & Chief Financial Officer, Andean Cluster at AstraZeneca, manages regional fiscal operations while contributing to broader corporate financial strategy. Overseeing financial planning for the Andean market, the Chief Financial Officer & Chief Financial Officer, Andean Cluster drives revenue growth through localized commercial strategies and efficient resource allocation. This leadership role involves navigating complex regulatory environments to ensure sustainable profitability across South American operations. By implementing robust financial controls, Santiago Rivera mitigates regional economic risks and optimizes supply chain investments. The Chief Financial Officer & Chief Financial Officer, Andean Cluster coordinates with global leadership to align regional performance with the overarching mission of delivering innovative medicines. Through meticulous oversight of regional budgets and capital expenditures, Rivera supports the expansion of the company's footprint in emerging markets, ensuring that financial health remains a cornerstone of the organization's commitment to improving patient outcomes.

Joey Zhu, the Chief Financial Officer, PA To The at AstraZeneca, executes critical financial oversight and administrative coordination to support executive decision-making. Overseeing the integration of financial data into strategic planning, the Chief Financial Officer, PA To The drives operational transparency across key business units. This leadership role involves facilitating communication between the finance department and senior leadership to ensure alignment on budgetary priorities. By refining internal reporting processes, Joey Zhu enhances the accuracy of fiscal forecasting for ongoing research and development projects. The Chief Financial Officer, PA To The manages complex administrative workflows that underpin the company's global commercial activities. Through diligent monitoring of financial performance indicators, Zhu provides the necessary insights to optimize resource allocation, ensuring that the organization maintains the fiscal agility required to advance its portfolio of prescription medicines and address unmet medical needs in the global biopharmaceutical landscape.

Richard Hasselbusch, the Vice President and Chief Financial Officer, Global Operations and Information Technology at AstraZeneca, directs the financial strategy for the company's manufacturing, supply chain, and digital infrastructure. Overseeing the integration of advanced technology into operational workflows, the Vice President and Chief Financial Officer, Global Operations and Information Technology drives cost-efficiency and scalability across global production sites. This leadership role involves managing large-scale capital investments in digital transformation to enhance data-driven decision-making. By optimizing the financial performance of the global supply chain, Richard Hasselbusch ensures the reliable delivery of medicines to patients worldwide. The Vice President and Chief Financial Officer, Global Operations and Information Technology coordinates with IT leadership to secure the technological foundation of the organization. Through rigorous financial oversight of operational and digital assets, Hasselbusch supports the company's commitment to innovation and operational excellence in the biopharmaceutical industry.

Gary Teo, the Chief Financial Officer, Cluster (Vietnam, Philippines) at AstraZeneca, manages fiscal operations and financial strategy within the Southeast Asian market. Overseeing regional budgetary planning, the Chief Financial Officer, Cluster (Vietnam, Philippines) drives revenue growth through localized commercial initiatives and efficient resource management. This leadership role involves navigating the unique economic and regulatory landscapes of Vietnam and the Philippines to ensure sustainable profitability. By implementing robust financial controls, Gary Teo mitigates regional risks and optimizes investments in local commercial infrastructure. The Chief Financial Officer, Cluster (Vietnam, Philippines) coordinates with global leadership to align regional performance with the company's overarching mission of delivering life-changing medicines. Through diligent monitoring of financial performance indicators, Teo provides the necessary insights to support the expansion of the company's footprint in these key emerging markets, ensuring that financial health remains a priority in the delivery of healthcare solutions.

Kevin Durning, the Chief Financial Officer (US) & Vice President, Finance Biopharmaceuticals at AstraZeneca, directs the financial strategy for the company's largest commercial market and its core biopharmaceutical portfolio. Overseeing financial planning and analysis for the US region, the Chief Financial Officer (US) & Vice President, Finance Biopharmaceuticals drives revenue growth through strategic investment in commercial operations and product launches. This leadership role involves managing complex financial structures to support the development and distribution of prescription medicines. By optimizing resource allocation across the biopharmaceutical business, Kevin Durning ensures that the organization maintains a competitive edge in the US healthcare market. The Chief Financial Officer (US) & Vice President, Finance Biopharmaceuticals coordinates with global leadership to align regional performance with the company's long-term scientific and commercial goals. Through rigorous financial oversight, Durning secures the economic stability necessary to advance the company's mission of improving patient outcomes.

Renee Iacona, the Chief Operating Officer, Oncology Research & Development at AstraZeneca, directs the operational infrastructure supporting the discovery and clinical advancement of oncology therapeutics. Overseeing the execution of complex research programs, the Chief Operating Officer, Oncology Research & Development drives efficiency in clinical trial management and laboratory operations. This leadership role involves coordinating cross-functional teams to accelerate the transition of drug candidates from early-stage research to commercialization. By optimizing resource utilization within the oncology pipeline, Renee Iacona ensures that scientific teams remain focused on high-impact patient outcomes. The Chief Operating Officer, Oncology Research & Development manages strategic partnerships with academic and clinical institutions to expand the company's research capabilities. Through rigorous operational oversight, Iacona facilitates the rapid development of innovative cancer treatments, ensuring that the organization maintains its position as a leader in the global biopharmaceutical industry while addressing critical patient needs.

Beth Clement, the Global HR Business Partner & To HR Chief of Staff at AstraZeneca, architects talent management frameworks that align human capital with scientific objectives. Overseeing organizational development initiatives, the Global HR Business Partner & To HR Chief of Staff drives cultural integration across international research hubs. This leadership role involves streamlining internal communication channels to enhance collaboration between clinical teams and commercial units. By implementing advanced performance metrics, Beth Clement fosters a high-performance environment conducive to rapid drug development. The Global HR Business Partner & To HR Chief of Staff manages complex workforce planning, ensuring the company retains top-tier scientific talent necessary for maintaining a competitive edge in the biopharmaceutical industry. Through strategic alignment of personnel resources with corporate goals, Clement supports the delivery of innovative medicines to patients worldwide, ensuring that the organizational structure remains agile and responsive to evolving global health challenges.

Jeff Pott, the Chief Human Resources Officer at AstraZeneca, architects the global talent strategy and organizational culture necessary to sustain scientific innovation. Overseeing the recruitment, development, and retention of a diverse workforce, the Chief Human Resources Officer drives initiatives that foster an inclusive and high-performance environment. This leadership role involves aligning human capital strategies with the company's long-term goals in biopharmaceutical research and commercialization. By implementing comprehensive leadership development programs, Jeff Pott ensures the organization possesses the expertise required to navigate complex global markets. The Chief Human Resources Officer manages total rewards and employee engagement strategies to attract top-tier scientific and commercial talent. Through strategic workforce planning, Pott supports the company's mission to deliver life-changing medicines, ensuring that the organizational culture remains resilient, innovative, and fully equipped to meet the evolving demands of the global healthcare sector.

Katharine Oteiza, the Director, BPO - Biometrics Chief of Staff at AstraZeneca, manages the operational integration of biometrics and data management processes within the research division. Overseeing the coordination of clinical data workflows, the Director, BPO - Biometrics Chief of Staff drives the implementation of standardized practices that ensure the integrity and quality of research outcomes. This leadership role involves facilitating communication between biometrics teams and clinical development leads to streamline the drug approval process. By optimizing data processing capabilities, Katharine Oteiza supports the rapid analysis of clinical trial results, which is essential for the development of new medicines. The Director, BPO - Biometrics Chief of Staff manages strategic initiatives that enhance the efficiency of the biometrics function, ensuring that data-driven insights are effectively utilized across the organization. Through meticulous oversight of operational processes, Oteiza contributes to the company's ability to deliver innovative therapies to patients.